ALS patients’ bone marrow cells capable of differentiating into nerve-supporting cells BrainStorm Cell Therapeutics Inc. , a respected developer of adult stem cell systems and therapeutics, announced today that bone marrow cells taken from ALS patients were with the capacity of differentiating into nerve-assisting cells. In addition, the cellular expansion potential of stem cells from the healthful donors and from the individuals was comparable. Related StoriesTUM researchers uncover signaling pathways that play vital role in self-renewal of blood stem cellsSCT, Thermo Fisher Scientific collaborate to advance development of cardiac disease modelsNYSCF, CBR collaborate to customize creation of high-quality stem cell linesBrainStorm will now complete all of its preparations for pre-scientific trials to be followed by clinical trials predicated on the business’s proposed stem cell therapy.Every year, about 200,000 Americans experience a stroke that seems to elude explanation, the researchers added. Possible underlying causes range from an intermittent and hard-to-detect irregular heartbeat , a blood coagulum disorder and/or a hole in the heart’s top chambers, according to background information in the news headlines release. But the poll revealed that between 51 % and 70 % of the respondents do not feel confident that they know precisely which steps are best to take in order to pinpoint precisely which cause might be at play for a specific patient. The study results were to be reported Fri at the AHA/ASA-sponsored Cryptogenic Stroke General public Health Conference, in Washington, D.C.